Literature DB >> 20560069

Isolation of mycobacterial RNA.

Tige R Rustad1, David M Roberts, Reiling P Liao, David R Sherman.   

Abstract

This chapter describes two protocols for isolating total RNA from mycobacteria: one for extraction from in vitro cultures and one for extraction from in vivo. In these protocols, RNA is liberated from mycobacteria by disruption with small glass beads in the presence of Trizol to stabilize the RNA. The RNA is further purified with DNAse treatment and RNeasy columns. This protocol leads to microgram quantities of RNA from log-phase cultures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20560069     DOI: 10.1007/978-1-59745-207-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  FurA contributes to the oxidative stress response regulation of Mycobacterium avium ssp. paratuberculosis.

Authors:  Elke Eckelt; Thorsten Meißner; Jochen Meens; Kristin Laarmann; Andreas Nerlich; Michael Jarek; Siegfried Weiss; Gerald-F Gerlach; Ralph Goethe
Journal:  Front Microbiol       Date:  2015-02-06       Impact factor: 5.640

2.  2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.

Authors:  Albert B Jeon; Andrés Obregón-Henao; David F Ackart; Brendan K Podell; Juan M Belardinelli; Mary Jackson; Tuan V Nguyen; Meghan S Blackledge; Roberta J Melander; Christian Melander; Benjamin K Johnson; Robert B Abramovitch; Randall J Basaraba
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

3.  An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans.

Authors:  Marie Robbe-Saule; Jérémie Babonneau; Odile Sismeiro; Laurent Marsollier; Estelle Marion
Journal:  Front Microbiol       Date:  2017-03-24       Impact factor: 5.640

4.  Construction of an overexpression library for Mycobacterium tuberculosis.

Authors:  Eduard Melief; Rachel Kokoczka; Megan Files; Mai Ann Bailey; Torey Alling; Hongye Li; James Ahn; Ayesha Misquith; Aaron Korkegian; David Roberts; James Sacchettini; Tanya Parish
Journal:  Biol Methods Protoc       Date:  2018-08-20

5.  Resuscitation of Dormant "Non-culturable" Mycobacterium tuberculosis Is Characterized by Immediate Transcriptional Burst.

Authors:  Elena G Salina; Artem S Grigorov; Oksana S Bychenko; Yulia V Skvortsova; Ilgar Z Mamedov; Tatyana L Azhikina; Arseny S Kaprelyants
Journal:  Front Cell Infect Microbiol       Date:  2019-07-30       Impact factor: 5.293

6.  RNA-Seq analysis of Mycobacterium avium non-coding transcriptome.

Authors:  Dmitriy Ignatov; Sofia Malakho; Konstantin Majorov; Timofey Skvortsov; Alexander Apt; Tatyana Azhikina
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

7.  Mycobacterium tuberculosis DosR is required for activity of the PmbtB and PmbtI promoters under hypoxia.

Authors:  Lise J Schreuder; Tanya Parish
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

8.  Identification of a lineage specific zinc responsive genomic island in Mycobacterium avium ssp. paratuberculosis.

Authors:  Elke Eckelt; Michael Jarek; Cornelia Frömke; Jochen Meens; Ralph Goethe
Journal:  BMC Genomics       Date:  2014-12-06       Impact factor: 3.969

9.  The Mycobacterium avium ssp. paratuberculosis specific mptD gene is required for maintenance of the metabolic homeostasis necessary for full virulence in mouse infections.

Authors:  Thorsten Meißner; Elke Eckelt; Tina Basler; Jochen Meens; Julia Heinzmann; Abdulhadi Suwandi; Walter M R Oelemann; Sandra Trenkamp; Otto Holst; Siegfried Weiss; Boyke Bunk; Cathrin Spröer; Gerald-F Gerlach; Ralph Goethe
Journal:  Front Cell Infect Microbiol       Date:  2014-08-14       Impact factor: 5.293

10.  Dormant non-culturable Mycobacterium tuberculosis retains stable low-abundant mRNA.

Authors:  Dmitriy V Ignatov; Elena G Salina; Mikhail V Fursov; Timofey A Skvortsov; Tatyana L Azhikina; Arseny S Kaprelyants
Journal:  BMC Genomics       Date:  2015-11-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.